Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             337 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abstract reviewers 2001
 20 2 p. 109-111
3 p.
 artikel
2 Accuracy of currently utilized clinical diagnostic strategy in primary pulmonary hypertension: validation against pathologic diagnosis Vensak, J.L.
 2001
 20 2 p. 175-
1 p.
 artikel
3 A classification system for severity of lung dysfunction after lung transplantation: a predictor of outcome Sekine, Y.
 2001
 20 2 p. 223-
1 p.
 artikel
4 A cluster of mycoplasma hominis infection in heart-lung transplantation Hopkins, P.
 2001
 20 2 p. 223-224
2 p.
 artikel
5 Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? Sharples, L.D.
 2001
 20 2 p. 197-
1 p.
 artikel
6 A dominant negative isoform of the serum-response factor (SRF) is increased in the failing human heart Gupta, M.
 2001
 20 2 p. 160-
1 p.
 artikel
7 Alloregulatory T cells producing TGFB/IL10 can be generated ex vivo Orosz, C.
 2001
 20 2 p. 229-
1 p.
 artikel
8 Allosensitization following left ventricular assist device (LVAD) implantation is dependent on CD40-CD40 ligand interactions Schuster, M.
 2001
 20 2 p. 211-212
2 p.
 artikel
9 Altered expression of tyrosine kinase receptors Her2/neu and GP130 following left ventricular assist device (LVAD) placement in patients with heart failure Uray, I.P.
 2001
 20 2 p. 210-
1 p.
 artikel
10 A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients Klepetko, W.
 2001
 20 2 p. 208-
1 p.
 artikel
11 A multi-institutional study of cardiac retransplantation: incidence, risk factors for mortality, and outcome Radovancevic, B.
 2001
 20 2 p. 181-
1 p.
 artikel
12 A murine model of left ventricular tissue engineering Krupnick, A.S.
 2001
 20 2 p. 197-198
2 p.
 artikel
13 Angiotensin II induces PAI-1 expression through MAP kinase-dependent, but TGF β and PI3 kinase-independent pathway Dong, C.
 2001
 20 2 p. 226-227
2 p.
 artikel
14 A novel contractile artificial myocardial tissue - on the way to the bioartificial heart Kofidis, T.
 2001
 20 2 p. 188-
1 p.
 artikel
15 A novel method based on computerized scoring of rejection for the prediction of coronary vascuolpathy validated by intravascular ultrasound Yamani, M.H.
 2001
 20 2 p. 150-
1 p.
 artikel
16 A novel scavenger of nitric oxide decreases heme protein nitrosylation and prolongs graft survivial during cardiac transplant rejection Pieper, G.M.
 2001
 20 2 p. 157-
1 p.
 artikel
17 Anti-CD25 therapy affects the death signals of activated T-cells after clinical heart transplantation Baan, C.C.
 2001
 20 2 p. 220-
1 p.
 artikel
18 Anti-thymocyte globulin treatment is associated with complement deposition in early cardiac transplant biopsies Baldwin, W.M.
 2001
 20 2 p. 155-156
2 p.
 artikel
19 Antiviral prophylaxis prevents lymphoprofilerative disease in lung transplant recipients Malouf, M.A.
 2001
 20 2 p. 200-
1 p.
 artikel
20 Aortic valve stenosis induced by left ventricular assist device (LVAD) Rose, A.G.
 2001
 20 2 p. 190-
1 p.
 artikel
21 Apoptosis in cardiac allograft rejection and its response to treatment Masri, S.C.
 2001
 20 2 p. 227-
1 p.
 artikel
22 A positive donor gram stain does not predict the development of pneumonia, oxygenation, or duration of mechanical ventilation following lung transplantation Weill, D.
 2001
 20 2 p. 255-
1 p.
 artikel
23 A randomised controlled trial of antihypertensive treatment with valsartan after heart transplantation Marcus, N.J.
 2001
 20 2 p. 246-
1 p.
 artikel
24 A randomized trial of inhaled nitric oxide to prevent reperfusion injury following lung transplantation Meade, M.
 2001
 20 2 p. 254-255
2 p.
 artikel
25 Are beta blockers effective in African Americans with systolic heart failure? Scott, R.L.
 2001
 20 2 p. 251-
1 p.
 artikel
26 Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients Costanzo, M.R.
 2001
 20 2 p. 152-
1 p.
 artikel
27 Assessment of coronary microcirculation in cardiac allografts. a comparison of intracoronary physiology, intravascular ultrasound and histological morphometry Escaned, J.
 2001
 20 2 p. 204-205
2 p.
 artikel
28 Assessment of myocardial recovery using dobutamine stress echocardiography in LVAD patients Khan, T.
 2001
 20 2 p. 202-203
2 p.
 artikel
29 Association of viral genome with transplant coronary arteriopathy and graft loss in children following cardiac transplantation Bowles, N.E.
 2001
 20 2 p. 198-
1 p.
 artikel
30 Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation Zuckermann, A.
 2001
 20 2 p. 163-
1 p.
 artikel
31 Beta-blocker therapy reduces mortality on the waiting list for cardiac transplantation Lanzenberger, M.E.
 2001
 20 2 p. 252-
1 p.
 artikel
32 Binding of anti-HLA class I antibodies to airway epithelial cells induces activation and growth factor production and indirectly upregulates lung fibroblast proliferation Jaramillo, A.
 2001
 20 2 p. 166-
1 p.
 artikel
33 Biopsy diagnosis of disease recurrence after transplantation (TX) for pulmonary sarcoidosis: a multicentre study Burke, M.
 2001
 20 2 p. 154-155
2 p.
 artikel
34 Blockade of PDGF receptor protein-tyrosine kinase activity effectively inhibits development of rat CMV infection enhanced experimental obliterative bronchiolitis Tikkanen, J.M.
 2001
 20 2 p. 167-
1 p.
 artikel
35 BLTX with intra- and postoperatively prolonged ECMO in patients with pulmonary hypertension: beneficial effect on initial organ function Wisser, W.
 2001
 20 2 p. 224-225
2 p.
 artikel
36 Bronchiolitis obliterans with organizing pneumonia: possible association with human herpes virus-7 infection after lung transplantation Ross, D.J.
 2001
 20 2 p. 171-
1 p.
 artikel
37 Bronchoalveolar lavage(BAL) neutrophilia in lung transplant recipients(LTR): infection and bronchiolitis obliterans syndrome(BOS), the chicken or the egg? Whitford, H.M.
 2001
 20 2 p. 260-
1 p.
 artikel
38 B-type natriuretic peptides (BNP and PRO-BNP) predict longterm survival in patients with advanced heart failure treated with atenolol Berger, R.
 2001
 20 2 p. 251-
1 p.
 artikel
39 Cardiac allografts with ischemic time over 300 minutes Tsai, F.
 2001
 20 2 p. 182-
1 p.
 artikel
40 Cardiac allograft vasculopathy in heart transplant recipients: a bacteriosclerosis by chlamydia pneumoniae? Wittwer, T.
 2001
 20 2 p. 196-
1 p.
 artikel
41 Cardiac resynchronisation therapy for advanced heart failure Oliva, F.
 2001
 20 2 p. 216-
1 p.
 artikel
42 Cardioprotective effects of ATP-sensitive potassium channel opener (cromakalim) in surgically induced cardiac arrest Lee, F.
 2001
 20 2 p. 181-
1 p.
 artikel
43 CD28/B7-2 pathway regulates the development of experimental obliterative bronchiolitis via promotion of TH1 cytokine expression Tikkanen, J.M.
 2001
 20 2 p. 252-253
2 p.
 artikel
44 CD8+ lymphocytes participate in the development of chronic rejection Fischbein, M.P.
 2001
 20 2 p. 228-229
2 p.
 artikel
45 Cell-mediated immunity to collagen V in lung transplant recipients: correlation with collagen V release into BAL fluid Wilkes, D.S.
 2001
 20 2 p. 167-
1 p.
 artikel
46 Change in physical and psychosocial domains of quality of life from before to after discharge post left ventricular assist device implantation Grady, K.L.
 2001
 20 2 p. 203-
1 p.
 artikel
47 Changes in the solid organ donor pool and the effect on cardiothoracic donation? Seeney, F.M.
 2001
 20 2 p. 242-
1 p.
 artikel
48 Chlamydia pneumoniae is associated with graft dysfunction after lung transplantation Glanville, A.R.
 2001
 20 2 p. 171-
1 p.
 artikel
49 Chronic therapy with the acorn cardiac support device in dogs with chronic heart failure: three and six months hemodynamic, histologic and ultrastructural findings Sabbah, H.N.
 2001
 20 2 p. 189-
1 p.
 artikel
50 Clinical experience with nine patients supported by the continuous flow Debakey VAD Wilhelm, M.J.
 2001
 20 2 p. 201-
1 p.
 artikel
51 Clinical outcome after starting carvedilol in infants and children with severe dilated cardiomyopathy candidates for heart transplantation Azeka, E.
 2001
 20 2 p. 222-
1 p.
 artikel
52 Clinical value of brain natriuretic peptide for candidate selection before cardiac transplantation Koglin, J.
 2001
 20 2 p. 164-
1 p.
 artikel
53 Co-administration of tacrolimus and mycophenolate mofetil does not increase mycophenolic acid (MPA) exposure, but co-administration of cyclosporine inhibits the enterohepatic recirculation of MPA, thereby decreasing its exposure Van Gelder, T.
 2001
 20 2 p. 160-161
2 p.
 artikel
54 Community acquired respiratory viruses in lung transplant patients: incidence and outcomes Hodges, T.N.
 2001
 20 2 p. 169-170
2 p.
 artikel
55 Comparative study of CSA and FK506 versus newer immunosuppressive drugs MMF and rapamycin on coronary endothelial function in vitro Jeanmart, H.
 2001
 20 2 p. 235-
1 p.
 artikel
56 Comparison of postoperative course of S100 protein and neuron-specific enolase in patients after implantation of axial and pulsatile flow LVADS Potapov, E.
 2001
 20 2 p. 190-191
2 p.
 artikel
57 Comparison of pretransplant transfusion with or without cyclosporin inhibition on post transplant outcome Pietra, B.
 2001
 20 2 p. 222-223
2 p.
 artikel
58 Comparison of total lymphoid irradiation (TLI) versus tacrolimus for the treatment of obliterative bronchiolitis (OB) in lung transplants Melville, A.
 2001
 20 2 p. 208-
1 p.
 artikel
59 Computerized heart allograft recipient monitoring (CHARM) - a multicenter study Grasser, B.
 2001
 20 2 p. 214-
1 p.
 artikel
60 Continuing medical education information 2001
 20 2 p. 112-113
2 p.
 artikel
61 Controlled perfusion decreases lung transplant reperfusion injury in the setting of high flow reperfusion Fiser, S.M.
 2001
 20 2 p. 183-
1 p.
 artikel
62 Coronary artery revascularization in eligible lung transplant recipients Patel, V.S.
 2001
 20 2 p. 223-
1 p.
 artikel
63 Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation Pelletier, M.P.
 2001
 20 2 p. 152-
1 p.
 artikel
64 Correlation between the glomerular filtratiion rate (GFR), serum creatinine (SCR), creatinine clearance (CRCL) and the calculated creatinine clearance (CALC CRCL) in heart transplant (HTX) patients (PTS) Cantarovich, M.
 2001
 20 2 p. 205-206
2 p.
 artikel
65 CTLA4Ig and donor-specific transfusion prolongs cardiac allograft survival in the miniature swine Lee, R.S.
 2001
 20 2 p. 150-
1 p.
 artikel
66 Current practices: immunosuppression induction, maintenance and rejection regimens in 213 consecutive transplant recipients Gass, A.
 2001
 20 2 p. 162-
1 p.
 artikel
67 Cyclosporine does not enhance the development of chronic rejection. Experimental study in a rat cardiac transplant model Richter, M.
 2001
 20 2 p. 234-
1 p.
 artikel
68 Cyclosporine verus tacrolimus in heart transplantation: an ISHLT/UNOS registry analysis Hosenpud, J.D.
 2001
 20 2 p. 161-162
2 p.
 artikel
69 Cytomegalovirus infection prophylaxis following heart transplantation: comparison of two regimes Antretter, H.
 2001
 20 2 p. 179-
1 p.
 artikel
70 Death after cardiac transplantation in low birth weight neonates Chinnock, R.
 2001
 20 2 p. 260-261
2 p.
 artikel
71 Depletion of recipient CD8+ T cells does not alter the development of cardiac allograft vasculopathy Szeto, W.Y.
 2001
 20 2 p. 219-
1 p.
 artikel
72 Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence Marie, P.Y.
 2001
 20 2 p. 193-194
2 p.
 artikel
73 Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental lung transplantation McRae, K.
 2001
 20 2 p. 184-
1 p.
 artikel
74 Determinants of early graft failure following cardiac transplantation, a 10-year, multi-institutional, multivariable analysis Young, J.B.
 2001
 20 2 p. 212-
1 p.
 artikel
75 Determinants of poor long-term survival after partial left ventriculectomy in patients with dilated cardiomyopathy Moreira, L.P.
 2001
 20 2 p. 217-218
2 p.
 artikel
76 Diabetes affects long-term survival after heart transplantation Czerny, M.
 2001
 20 2 p. 245-
1 p.
 artikel
77 Diabetes related complications in patients after heart transplantation Czerny, M.
 2001
 20 2 p. 245-
1 p.
 artikel
78 Diagnostic yield of follow-up transbronchial lung biopsies after acute rejection in lung transplant recipients Aboyoun, C.L.
 2001
 20 2 p. 258-259
2 p.
 artikel
79 Differential modulation of alloreactive T cell receptor expression induced by allogeneic bone marrow and splenocyte infusions George, J.F.
 2001
 20 2 p. 172-
1 p.
 artikel
80 1,25-dihydroxycholecalciferol reduces acute rejection in rat lung allotransplantation Kubisa, B.
 2001
 20 2 p. 254-
1 p.
 artikel
81 Direct fluorescent antibody testing in the diagnosis of influenzae infection in lung transplant recipients Hopkins, P.M.
 2001
 20 2 p. 170-
1 p.
 artikel
82 Dobutamine/atropine stress echocardiography: feasibility, safety and early results in paediatric heart transplant recipients Dipchand, A.I.
 2001
 20 2 p. 232-
1 p.
 artikel
83 Does HDL-cholesterol level predict clinical outcome in advanced heart failure? Mehra, M.R.
 2001
 20 2 p. 165-
1 p.
 artikel
84 Does hyperuricemia predict adverse clinical outcome while awaiting heart transplantation? Uber, P.A.
 2001
 20 2 p. 164-165
2 p.
 artikel
85 Does unloading the heart by a left ventricular assist device result in sustained reversal of myocyte dysfunction in end-stage heart failure? De Jonge, N.
 2001
 20 2 p. 202-
1 p.
 artikel
86 Donor or recipient origin of post transplant lymphoproliferative disease after lung transplantation Verschuuren, E.A.
 2001
 20 2 p. 199-
1 p.
 artikel
87 Do vascular compartments differ in the development of chronic rejection? Richter, M.
 2001
 20 2 p. 186-
1 p.
 artikel
88 Early experience with sirolimus in lung transplant recipients Cahill, B.
 2001
 20 2 p. 162-
1 p.
 artikel
89 Early T lymphocyte trafficking after allo-transplantation Legare, J.
 2001
 20 2 p. 156-157
2 p.
 artikel
90 EBV mismatching and HLA matching post lung transplantation: key risk factors for post transplant lymphoproliferative disease(PTLD) Wong, J.Y.
 2001
 20 2 p. 199-
1 p.
 artikel
91 Effect of controlled reperfusion techniques in human lung transplantation Alvarado, C.G.
 2001
 20 2 p. 183-184
2 p.
 artikel
92 Effect of Daclizumab induction therapy on the development of cardiac transplant vasculopathy Mancini, D.
 2001
 20 2 p. 194-
1 p.
 artikel
93 Effect of HLA-DR mismatch on lung transplant outcome Love, R.B.
 2001
 20 2 p. 177-
1 p.
 artikel
94 Effect of the abiocor implantable replacement heart on immune system function Kaufman, C.L.
 2001
 20 2 p. 240-
1 p.
 artikel
95 Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study Channick, R.
 2001
 20 2 p. 262-263
2 p.
 artikel
96 Efficacy and safety of atorvastatin after pediatric cardiac transplantation Chin, C.
 2001
 20 2 p. 230-
1 p.
 artikel
97 Efficacy trends of the acorn cardiac support device in patients with heart failure: a one year follow-up Sabbah, H.N.
 2001
 20 2 p. 217-
1 p.
 artikel
98 Efficiency, efficacy and adverse effects of adenovirus versus liposome-mediated ex vivo immunosuppressive cytokine gene transfer on the functional cardiac allografts Sen, L.
 2001
 20 2 p. 184-185
2 p.
 artikel
99 Elevation of serum big endothelin is associated with endothelial dysfunction in patients with chronic heart failure Berger, R.
 2001
 20 2 p. 159-
1 p.
 artikel
100 Empirical supportive therapy in the hypotensive donor - best guess or worst option? Satchithananda, D.K.
 2001
 20 2 p. 255-
1 p.
 artikel
101 Endothelial-cell selective CTL arise from limited precursor subsets of alloreactive CD8+ T cells and show reduced clonal expansion Dengler, T.J.
 2001
 20 2 p. 171-172
2 p.
 artikel
102 Endothelial function after brain death Szabo, G.
 2001
 20 2 p. 153-
1 p.
 artikel
103 Eotaxin and prednisolone concentrations regulate the mobilisation of peripheral blood eosinophils preceding heart allograft rejection Trull, A.K.
 2001
 20 2 p. 161-
1 p.
 artikel
104 European multicenter tacrolimus heart pilot study: three year follow-up Reichart, B.
 2001
 20 2 p. 249-250
2 p.
 artikel
105 Evaluation of extended donor and recipient criteria for lung transplantation Pierre, A.F.
 2001
 20 2 p. 256-
1 p.
 artikel
106 Evaluation of pre-transplant sensitization: a survey of tissue typing laboratories Graff, R.
 2001
 20 2 p. 195-
1 p.
 artikel
107 Even slightly impaired kideny function (creatinine>1.79 MMOL/L) one year after cardiac transplantation has a negative impact on long term survival Zuckermann, A.
 2001
 20 2 p. 206-
1 p.
 artikel
108 Evolution and significance of HLA allosensitization during ventricular assist device support Kumpati, G.S.
 2001
 20 2 p. 210-211
2 p.
 artikel
109 Exhaled no (ENO) after lung transplantation (LTX): a prospective study Verleden, G.
 2001
 20 2 p. 208-
1 p.
 artikel
110 Extended lung preservation with UW solution does not adversely affect graft outcome Woolley, D.S.
 2001
 20 2 p. 207-
1 p.
 artikel
111 Extending myocardial preservation with cyclosporine a treatment Masters, T.N.
 2001
 20 2 p. 182-
1 p.
 artikel
112 Extracorporeal membrane oxygenation for neonates with single ventricle and parallel circulations Pizarro, C.
 2001
 20 2 p. 239-240
2 p.
 artikel
113 Familial and sporadic primary pulmonary hypertension is caused by BMPR2 gene mutations resulting in haploinsufficiency of the bone morphogenetic protein tùype II receptor Thomson, J.
 2001
 20 2 p. 149-
1 p.
 artikel
114 FAS-FAS ligand death pathway does not contribute to CTL-mediated apoptosis of mouse vascular endothelium Krupnick, A.S.
 2001
 20 2 p. 218-219
2 p.
 artikel
115 Features of bronchoalveolar lavage (BAL) in lung transplant recipients (LTR) who later develop bronchiolitis obliterans syndrome (BOS) Whitford, H.M.
 2001
 20 2 p. 176-
1 p.
 artikel
116 First results 24 hours after orthotopic heart transplantation from non-heart-beating donors in pigs Martin, J.R.
 2001
 20 2 p. 153-
1 p.
 artikel
117 FK506 vs. cyclosporin: pathologic findings in 1067 endomyocardial biopsies Gajjar, N.A.
 2001
 20 2 p. 229-
1 p.
 artikel
118 Fluvastatin in combination with RAD significantly reduces transplant coronary vasculopathy in rat cardiac allografts Gregory, C.R.
 2001
 20 2 p. 253-
1 p.
 artikel
119 Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in lung transplant patients Verschuuren, E.A.
 2001
 20 2 p. 199-200
2 p.
 artikel
120 Functional relevance of sympathetic reinnervation for the transplanted heart Ueberfuhr, P.
 2001
 20 2 p. 169-
1 p.
 artikel
121 Functional status and medical complications during the first year post lung transplantation (LTX) Lanuza, D.M.
 2001
 20 2 p. 204-
1 p.
 artikel
122 General meeting information 2001
 20 2 p. 114-
1 p.
 artikel
123 Graft accommodation in infant recipients of ABO-incompatible heart transplants: donor ABH antigen expression in graft biopsies West, L.J.
 2001
 20 2 p. 222-
1 p.
 artikel
124 Haptoglobin polymorphism influences the development of cardiac transplant vasculopathy Densem, C.G.
 2001
 20 2 p. 151-
1 p.
 artikel
125 Health-promoting lifestyle and quality of life in long-term cardiac transplant recipeints Salyer, J.J.
 2001
 20 2 p. 203-204
2 p.
 artikel
126 Heart failure (HF): are nurses providing patients with optimal education of self-care principles? Albert, N.M.
 2001
 20 2 p. 244-
1 p.
 artikel
127 Heart-lung transplantation for Eisenmenger’s syndrome: operative risks and late outcomes of 51 consecutive cases from a single institution Stoica, S.C.
 2001
 20 2 p. 173-174
2 p.
 artikel
128 Heart transplantation in Friedreich’s ataxia and other neuromuscular diseases Segovia, J.
 2001
 20 2 p. 169-
1 p.
 artikel
129 Heart transplantation in the older recipient: has the time come to reconsider our selection policies? Hoercher, K.
 2001
 20 2 p. 204-
1 p.
 artikel
130 Hemodynamic exercise testing reveals a low incidence of myocardial recovery in LVAD patients El-Banayosy, A.
 2001
 20 2 p. 209-210
2 p.
 artikel
131 Hepatic source of C6 drives complement-mediated cardiac allograft injury Qian, Z.
 2001
 20 2 p. 227-
1 p.
 artikel
132 Hepatitis C virus infection after lung transplantation: dim prognosis Carreno, M.C.
 2001
 20 2 p. 224-
1 p.
 artikel
133 Heterotopic abdominal heart transplantation: the answer to the donor shortage? Caparrelli, D.J.
 2001
 20 2 p. 187-188
2 p.
 artikel
134 Highlights of the scientific program 2001
 20 2 p. 115-
1 p.
 artikel
135 Histopathology of rejection in the pig-to-primate cardiac xenograft model Goddard, M.J.
 2001
 20 2 p. 216-
1 p.
 artikel
136 HMG-COA reductase inhibitor cerivastatin prolonged rat cardiac allograft survival by blocking intercellular signals Horimoto, H.
 2001
 20 2 p. 227-
1 p.
 artikel
137 Homocysteine/coronary atherosclerosis and cardiac transplantation:a case control study Kundur, R.N.
 2001
 20 2 p. 196-
1 p.
 artikel
138 Hospital transfer of patients for LVAD bridge to transplant: is timing really critical to success? Hoercher, K.
 2001
 20 2 p. 209-
1 p.
 artikel
139 Human T cells express CD86 and acquire APC function after stimulation with human or porcine APC Popma, S.H.
 2001
 20 2 p. 215-
1 p.
 artikel
140 Humoral and echo-Doppler parameters in predicting the benefits of betablockers in patients with dilated cardiomyopathy Tack, W.
 2001
 20 2 p. 233-
1 p.
 artikel
141 Hypertonic saline challenge predicts early onset bronchiolitis obliterans syndrome post-lung transplantation Reid, D.
 2001
 20 2 p. 260-
1 p.
 artikel
142 Hypotensive reactions associated with transfusion of bedside leukocyte reduction filtered blood products in heart transplanted patients Lavee, J.
 2001
 20 2 p. 249-
1 p.
 artikel
143 IL-4 promotor gene polymorphism in heart transplantation Bijlsma, F.
 2001
 20 2 p. 157-
1 p.
 artikel
144 Immediate renal replacement therapy and outcome after cardiac transplantation − a multivariate analysis of risk factors Saeed, I.
 2001
 20 2 p. 257-
1 p.
 artikel
145 Immunohistochemical localization of oxidized low-density lipoprotein (OXLDL) and macrophages in coronary arteries: human heart allografts versus human native hearts McDonald, P.C.
 2001
 20 2 p. 187-
1 p.
 artikel
146 Immunolocalisation of BMPR-II and TGF-ß type I and II receptors in primary plexogenic pulmonary hypertension Atkinson, C.
 2001
 20 2 p. 149-
1 p.
 artikel
147 Immunologic events and long term survival after combined heart and kidney transplantation : a twelve-year single-center experience Vermes, E.
 2001
 20 2 p. 247-
1 p.
 artikel
148 Impact of antibiotic-resistant pseudomonas on the survival of cystic fibrosis (CF) patients following heart-lung transplantation Smith, S.R.
 2001
 20 2 p. 224-
1 p.
 artikel
149 Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD: is there a difference in models of the disease? Valantine, H.
 2001
 20 2 p. 186-187
2 p.
 artikel
150 Impaired vasodilation during endothelin-A receptor blockade in lung transplanted patients Silverborn, M.
 2001
 20 2 p. 226-
1 p.
 artikel
151 Impairment of cytolytic activity in allograft environment affects early medial cell loss but does not alter outcome of allograft arteriosclerosis O’Neill, J.L.
 2001
 20 2 p. 159-
1 p.
 artikel
152 Improved myocardial structure following LVAD support: effect of unloading on dystrophin expression Stetson, S.J.
 2001
 20 2 p. 240-
1 p.
 artikel
153 Improvement of acute renal dysfunction (ARD) in heart transplant (TX) patients (PTS) during calcineurin inhibitor (CNI) ‘holiday’ without rejection under anti-CD25 monoclonal antibody (MAB) coverage Cantarovich, M.
 2001
 20 2 p. 233-
1 p.
 artikel
154 Improvement of cardiac allograft function by 1400W, a highly selective inducible nitric oxide synthase inhibitor and superoxide dismutase − role of peroxynitrite Egi, K.
 2001
 20 2 p. 154-
1 p.
 artikel
155 Improvement of chronic renal failure after introduction of mycophenolate mofetil and reduction of cyclosporine dose RÁbago, G.
 2001
 20 2 p. 193-
1 p.
 artikel
156 Incidence of bronchiolitis obliterans syndrome unaffected by absence of cytomegalovirus Luckraz, H.
 2001
 20 2 p. 170-171
2 p.
 artikel
157 Incidence of erectile dysfunction and efficacy of sildenafil in the cardiac transplantation patient Wren, F.J.
 2001
 20 2 p. 246-
1 p.
 artikel
158 Increased death inducing receptors in vivo and activation-induced T-cell death by anti-thymocyte antibody treatment of stable cardiac transplant recipients Ankersmit, H.
 2001
 20 2 p. 187-
1 p.
 artikel
159 Increased risk of CMV infection in heart transplant patients on mycophenolate mofetil Giesler, G.
 2001
 20 2 p. 178-
1 p.
 artikel
160 Index to authors of abstracts 2001
 20 2 p. 265-277
13 p.
 artikel
161 Indirect allorecognition and alloantibody production precede obliterative airway disease development after tracheal transplantation in mice Smith, M.
 2001
 20 2 p. 158-
1 p.
 artikel
162 Indirect alloresponses are more pronounced in non-rejecting lung than heart allografts Webber, S.A.
 2001
 20 2 p. 165-166
2 p.
 artikel
163 Inducible expression of basic transcription factor binding protein 2 plays a potential role in the development of the allograft vascular disease Ogata, T.
 2001
 20 2 p. 228-
1 p.
 artikel
164 Influence of four different immunosuppressive protocols on acute and chronic rejection (BOS) after lung transplantation - experiences in 120 patients Treede, H.
 2001
 20 2 p. 176-
1 p.
 artikel
165 Influence of graft ischemia time on outcomes following lung transplantation Fiser, S.M.
 2001
 20 2 p. 206-207
2 p.
 artikel
166 Influence of methilenethetraidrofolate reductase polymorphism on total homocysteine plasma levels in heart transplant recipients Potena, L.
 2001
 20 2 p. 257-258
2 p.
 artikel
167 Initial experience with the Jarvik 2000 left ventricular assist system as a bridge to transplantation: report of 4 cases Frazier, O.H.
 2001
 20 2 p. 201-
1 p.
 artikel
168 Interaction of volume and era on survival of children listed for cardiac transplantation Balfour, I.
 2001
 20 2 p. 262-
1 p.
 artikel
169 Interleukin-10 gene targeting induced apoptosis of alloractive T cell via FAS/FASL pathway Oshima, K.
 2001
 20 2 p. 220-221
2 p.
 artikel
170 Interleukin-2-receptor blockade with daclizumab decreases the incidence of acute rejection in pediatric lung transplant recipients Sweet, S.C.
 2001
 20 2 p. 221-222
2 p.
 artikel
171 Interleukin-8 release during ischemia-reperfusion correlates with early graft function in human lung transplantation De Perrot, M.
 2001
 20 2 p. 175-176
2 p.
 artikel
172 International society for heart and lung transplantation 2001
 20 2 p. 107-
1 p.
 artikel
173 Interstitial pneumonitis after lung or heart-lung transplantation in very young recipients Hoffman, T.M.
 2001
 20 2 p. 155-
1 p.
 artikel
174 Interventional bronchoscopy for the management of airway complications following lung transplantation Chhajed, P.N.
 2001
 20 2 p. 177-
1 p.
 artikel
175 Intervention prevents progression of osteoporosis in patients awaiting lung transplantation Lien, D.
 2001
 20 2 p. 225-
1 p.
 artikel
176 Intrathoracic organ transplantation for patients with primary pulmonary hypertension Saeed, I.
 2001
 20 2 p. 174-
1 p.
 artikel
177 Intrathoracic organ transplantation in adults with congenital heart disease Saeed, I.
 2001
 20 2 p. 261-
1 p.
 artikel
178 Intravenous immunoglobulin therapy in highly sensitized cardiac allograft recipients facilitates transplantation across donor specific IGG positive cross matches John, R.
 2001
 20 2 p. 213-
1 p.
 artikel
179 Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with chronic renal insufficiency Garlicki, M.
 2001
 20 2 p. 193-
1 p.
 artikel
180 Invasive pneumoccoccal infection in pediatric heart transplant patients Stovall, S.
 2001
 20 2 p. 231-
1 p.
 artikel
181 In vivo donor adenoviral-mediated transtracheal transfection of human IL-10 (HIL-10) gene ameliorates ischemia-reperfusion (IR) injury and enhances transplanted lung function. Fischer, S.
 2001
 20 2 p. 152-153
2 p.
 artikel
182 In vivo effect of sirolimus on T cells, B cells and monocytes in non-human primates. Dambrin, C.
 2001
 20 2 p. 234-
1 p.
 artikel
183 In vivo monitoring of myoblast transplantation into rat myocardium Koransky, M.L.
 2001
 20 2 p. 188-189
2 p.
 artikel
184 ISATX247: a novel calcineurin inhibitor Abel, M.D.
 2001
 20 2 p. 161-
1 p.
 artikel
185 Is carvedilol safe and efficaceous in severe heart failure patients accepted for heart transplantation? Angermann, C.E.
 2001
 20 2 p. 250-251
2 p.
 artikel
186 Is outcome after heart transplantation influenced by ethnicity? A comparison of African Americans versus Caucasians Pamboukian, S.V.
 2001
 20 2 p. 238-
1 p.
 artikel
187 Is renal function in paediatric heart transplant recipients influenced by late reduction in cyclosporine dosage? Rice, J.E.
 2001
 20 2 p. 232-
1 p.
 artikel
188 Left ventricular assist device support for medically unresponsive pulmonary hypertension from left ventricular failure Nguyen, D.Q.
 2001
 20 2 p. 190-
1 p.
 artikel
189 Longer distance from transplant center is not associated with decreased survival in post cardiac transplant patients Kushwaha, S.
 2001
 20 2 p. 236-237
2 p.
 artikel
190 Long term follow-up of sensitized patients Pisani, B.A.
 2001
 20 2 p. 194-195
2 p.
 artikel
191 Long-term outcomes of dynamic cardiomyoplasty: what we learned and challenges for future applications Moreira, L.P.
 2001
 20 2 p. 189-
1 p.
 artikel
192 Long-term post-transplant quality of life outcomes in patients bridged to transplant with ventricular assist devices Dew, M.A.
 2001
 20 2 p. 203-
1 p.
 artikel
193 Long-term renal function in heart transplant recipients receiving tacrolimus (FK506) therapy Stempfle, H.
 2001
 20 2 p. 256-
1 p.
 artikel
194 Long term results of hyperimmunoglobulin CMV-prophylaxis in 377 heart transplant recipients Kocher, A.A.
 2001
 20 2 p. 178-
1 p.
 artikel
195 Low expression of ecto-5’-nucleotidase in the pig heart - a potential barrier to xenotransplantation Smolenski, R.
 2001
 20 2 p. 214-215
2 p.
 artikel
196 Low incidence of graft arteriosclerosis after cardiac transplantation - risk factor analysis for patients with induction therapy Zuckermann, A.
 2001
 20 2 p. 196-
1 p.
 artikel
197 Lung transplantation for cystic fibrosis; the effect of B cepacia genomovars on post transplant outcomes De Soyza, A.
 2001
 20 2 p. 158-
1 p.
 artikel
198 Lung transplantation for lymphangioleiomyomatosis Pechet, T.T.
 2001
 20 2 p. 174-
1 p.
 artikel
199 Lung transplantation in children following treatment for mallignancy Huddleston, C.B.
 2001
 20 2 p. 221-
1 p.
 artikel
200 Lung transplantation in patients with scleroderma Kubo, M.
 2001
 20 2 p. 174-175
2 p.
 artikel
201 LVAD blood stream infection: therapeutic rationale for transplantation Poston, R.S.
 2001
 20 2 p. 241-242
2 p.
 artikel
202 LVAD therapy improves utilization of donor hearts: implications for prolonged inotropic therapy Aaronson, K.
 2001
 20 2 p. 241-
1 p.
 artikel
203 LVAD treated heart recipients do not have deleterious HLA antibody Kerman, R.H.
 2001
 20 2 p. 211-
1 p.
 artikel
204 Matrixmetalloproteinase (MMP) 9 activity and impaired coronary vasomotor function after cardiac transplantation in rats. Wildhirt, S.M.
 2001
 20 2 p. 157-158
2 p.
 artikel
205 Mechanical unloading causes recovery of calcium cycling in the failing human heart Ogletree-Hughes, M.L.
 2001
 20 2 p. 210-
1 p.
 artikel
206 Mechanical unloading decreases the expression of beta-tubulin in the failing human heart Aquila-Pastir, L.A.
 2001
 20 2 p. 211-
1 p.
 artikel
207 Mechanisms of tolerance induction in the heart/kidney model in miniature swine Mezrich, J.D.
 2001
 20 2 p. 172-173
2 p.
 artikel
208 Membrane transport of mycophenolate mofetil and its active metabolite, mycophenolic acid in MDCK and MDR1-MDCK cell monolayers Sawamoto, T.
 2001
 20 2 p. 234-235
2 p.
 artikel
209 Metoprolol reduces sympathetic nerve hyperactivity in patients with heart failure Rundqvist, B.
 2001
 20 2 p. 251-252
2 p.
 artikel
210 MMF-a new cornerstone in immunosuppressive therapy after cardiac transplantation Richter, M.
 2001
 20 2 p. 235-
1 p.
 artikel
211 MMF significantly reduces the transendothelial migration of graft infiltrating leucocytes. Richter, M.
 2001
 20 2 p. 253-254
2 p.
 artikel
212 Monoclonal gammopathy in heart transplantation: clinical significance and risk factors Caforio, A.L.
 2001
 20 2 p. 237-
1 p.
 artikel
213 Monotherapy with anti-CD40 ligand antibody (IDEC 131) for non-human primate allograft heart transplantation Pfeiffer, S.
 2001
 20 2 p. 250-
1 p.
 artikel
214 Monthly infusion of cytomegalovirus immune globulin (CMVIG) decreases the incidence of bacterial and fungal infections in the first year following lung transplantation Zamora, M.R.
 2001
 20 2 p. 200-
1 p.
 artikel
215 Morbidity and mortality beyond the 10th year following heart transplant. Data from a population of 137 patients Sebbag, L.
 2001
 20 2 p. 180-
1 p.
 artikel
216 Mouse vascular endothelium activates alloreactive CD8+ T lymphocytes in B-7 dependent fashion Kreisel, D.
 2001
 20 2 p. 249-
1 p.
 artikel
217 Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation Frazier, O.H.
 2001
 20 2 p. 201-202
2 p.
 artikel
218 Mutations in the TGF-beta type 1 receptor, ALK1, in combined primary pulmonary hypertension and hereditary haemorrhagic telangiectasia, implies pathway specificity Trembath, R.C.
 2001
 20 2 p. 175-
1 p.
 artikel
219 Myocardial ischemic injury following heart transplantation is associated with decreased risk of acute cellular rejection in the absence of humoral rejection Yamani, M.H.
 2001
 20 2 p. 238-
1 p.
 artikel
220 Myosplint implantation and ventricular shape change in patients with dilative cardiomyopathy- first clinical experience Schenk, S.
 2001
 20 2 p. 217-
1 p.
 artikel
221 Native lung volume reduction surgery following single lung transplantation (SLTX) for emphysema Negri, J.C.
 2001
 20 2 p. 177-
1 p.
 artikel
222 Native ventricular performance after one year of left ventricular support El-Banayosy, A.
 2001
 20 2 p. 240-
1 p.
 artikel
223 Neonatal infusion of allogeneic fetal liver cells induces non-specific acceptance of cardiac allografts without diminution of alloreactivity to skin grafts and in vitro assays West, L.J.
 2001
 20 2 p. 173-
1 p.
 artikel
224 Neutralization of tumor necrosis factor-alpha or interleukin-1 prevents obliterative airway disease in HLA-A2 transgenic murine tracheal allografts. Smith, C.
 2001
 20 2 p. 166-167
2 p.
 artikel
225 Nitric oxide inhalation modulates endothelin-1 and big endothelin-1 after left ventricular assist device implantation Wagner, F.D.
 2001
 20 2 p. 241-
1 p.
 artikel
226 Nitric oxide regulates the apoptotic pathway in explanted failing human hearts Mital, S.
 2001
 20 2 p. 220-
1 p.
 artikel
227 NKH477, a forskolin derivative, exerts an antiproliferative effect in vivo with an altered cytokine profile in rat recipients of orthotopic lung allografts Morikawa, M.
 2001
 20 2 p. 254-
1 p.
 artikel
228 Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS) Fisher, A.
 2001
 20 2 p. 259-
1 p.
 artikel
229 Nonimmunologic rejection of the heart Labarrere, C.A.
 2001
 20 2 p. 155-
1 p.
 artikel
230 Older recipient age is associated with reduced alloreactivity and graft rejection after cardiac transplantation John, R.
 2001
 20 2 p. 212-
1 p.
 artikel
231 One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation Corris, P.
 2001
 20 2 p. 149-150
2 p.
 artikel
232 Optimal management of severe tricuspid regurgitation in cardiac transplant recipients Anderson, C.
 2001
 20 2 p. 247-
1 p.
 artikel
233 Optimizing heart transplant patient education: is once enough? Bordelon, A.
 2001
 20 2 p. 243-244
2 p.
 artikel
234 Outcome after diagnosis of moderate-severe transplant coronary artery disease (TCAD) in pediatric heart transplant recipients Hirsch, R.
 2001
 20 2 p. 261-262
2 p.
 artikel
235 Outcome of heart transplant in patients with renal insufficiency Adajar, F.L.
 2001
 20 2 p. 248-
1 p.
 artikel
236 Outcome of hepatitis C positive donors in cardiac transplant recipients in triple drug immunosuppression (TDI) Tsai, F.
 2001
 20 2 p. 177-178
2 p.
 artikel
237 Oxidative stress of cardiac transplantation is associated with decreased BCL-2 expression and increased NFKB activity Miniati, D.N.
 2001
 20 2 p. 158-159
2 p.
 artikel
238 Paediatric heart transplantation in the United Kingdom − a five year review of practice and results Saeed, I.
 2001
 20 2 p. 262-
1 p.
 artikel
239 Panel reactive antibody screening practices prior to heart transplantation Betkowski, A.S.
 2001
 20 2 p. 205-
1 p.
 artikel
240 Patients at risk for post-transplant lymphoproliferative disease can be identified in the first months after lung transplantation by quantitative-competitive-EBV-PCR Verschuuren, E.A.
 2001
 20 2 p. 199-
1 p.
 artikel
241 Pediatric living donor lung transplantation: psychosocial considerations Markovitz, M.S.
 2001
 20 2 p. 245-
1 p.
 artikel
242 Pediatric lung transplantation and CMV pneumonitis: a ten year experience De La Morena, M.
 2001
 20 2 p. 221-
1 p.
 artikel
243 Peripheral expansion of circulating TH1 cells predicts coronary endothelial dysfunction after cardiac transplantation Koglin, J.
 2001
 20 2 p. 173-
1 p.
 artikel
244 Pharmacodynamic (PD) measurements of the immunosuppressive effects of the combination of cyclosporine (CY) and mycophenolate mofetil (MMF): correlation between drug dose and lymphocyte function Gummert, J.F.
 2001
 20 2 p. 163-
1 p.
 artikel
245 Pituitary stimulation in cardiac transplant recipients with low free testosterone levels Edwards, J.
 2001
 20 2 p. 248-
1 p.
 artikel
246 Plasma exchange before and after cardiac transplantation Abdo, A.S.
 2001
 20 2 p. 194-
1 p.
 artikel
247 Posttransplantation lymphoproliferative disease in heart and heart-lung transplant recipients: thirty years experience at our hospital Chaparro, S.
 2001
 20 2 p. 258-
1 p.
 artikel
248 Predicting a patient’s waiting time to heart transplant in the UK. Seeney, F.M.
 2001
 20 2 p. 165-
1 p.
 artikel
249 Predictive factors for weaning from a cardiac assist device. An analysis of clinical, gene expression, and protein data Mueller, J.
 2001
 20 2 p. 202-
1 p.
 artikel
250 Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis Egan, T.M.
 2001
 20 2 p. 242-
1 p.
 artikel
251 Pregnancy after heart-lung transplantation Baron, O.
 2001
 20 2 p. 225-226
2 p.
 artikel
252 Preliminary experience with IVUS in pediatric heart transplant recipients Costello, J.
 2001
 20 2 p. 231-
1 p.
 artikel
253 Preoperative amiodarone increases risk of bleeding complications following cardiac transplantation Blomberg, P.
 2001
 20 2 p. 237-238
2 p.
 artikel
254 Prevalence and outcome of hepatitis B virus (HBV) infection following thoracic organ transplantation Grossi, P.
 2001
 20 2 p. 179-
1 p.
 artikel
255 Prevalence of sleep disordered breathing after lung transplantation Malouf, M.A.
 2001
 20 2 p. 225-
1 p.
 artikel
256 Prevention of accelerated rejection and prolonged survival in sensitized rats with cyclophosphamide therapy Ma, N.
 2001
 20 2 p. 233-234
2 p.
 artikel
257 Prevention of osteoporosis in cardiac transplant recipients Dusek, L.K.
 2001
 20 2 p. 257-
1 p.
 artikel
258 Procalcitonin: a donor-specific predictor of early graft failure and early graft failure mortality after heart transplantation Wagner, F.D.
 2001
 20 2 p. 206-
1 p.
 artikel
259 Procalcitonin (PCT) is a new biological marker for the diagnosis of non-viral infections after transplantation of intrathoracic organs Qedra, N.
 2001
 20 2 p. 239-
1 p.
 artikel
260 Prognostic value of a new intravascular ultrasound score in graft vessel disease Segovia, J.
 2001
 20 2 p. 151-
1 p.
 artikel
261 Program section 2001
 20 2 p. 117-147
31 p.
 artikel
262 Prospective randomized clinical study of Celsior vs University of Wisconsin in double lung transplant D’armini, A.M.
 2001
 20 2 p. 183-
1 p.
 artikel
263 Pulmonary vein gas analysis for assessing of donor lung function Aziz, T.
 2001
 20 2 p. 255-
1 p.
 artikel
264 Ratings of children’s self perception before and one year after transplantation: do children and their parents agree? Wray, J.C.
 2001
 20 2 p. 243-
1 p.
 artikel
265 Recipient cells form the proliferative lesion in the rat heterotopic tracheal allograft model of obliterative airway disease (OAD) Jordan, J.L.
 2001
 20 2 p. 166-
1 p.
 artikel
266 Recipient intramuscular gene transfer of naked plasmid TGFβ1 ameliorates lung graft reperfusion injury Daddi, N.
 2001
 20 2 p. 184-
1 p.
 artikel
267 Recipient treatment with trimetazidine improves graft function and protects the energy status after lung transplantation Inci, I.
 2001
 20 2 p. 153-154
2 p.
 artikel
268 Relationship between peak exercise oxygen consumption and QTC in patients with advanced heart failure Boccalandro, F.
 2001
 20 2 p. 164-
1 p.
 artikel
269 Retransplantation of intrathoracic organs − is a cautious approach still justified? Saeed,
 2001
 20 2 p. 180-181
2 p.
 artikel
270 Reversal of chronic cyclosporin nephrotoxicity after heart transplantation Tedoriya, T.
 2001
 20 2 p. 247-248
2 p.
 artikel
271 Right atrial geometry and tricuspid regurgitation after orthotopic heart transplantation: benefits of a modified biatrial surgical technique Dandel, M.
 2001
 20 2 p. 246-247
2 p.
 artikel
272 Risk factors and outcome in patients with hemodynamically unstable rejection after heart transplantation Jimenez, J.
 2001
 20 2 p. 193-
1 p.
 artikel
273 Safety and efficacy of pravastatin in pediatric heart transplant recipients Pahl, E.
 2001
 20 2 p. 230-
1 p.
 artikel
274 Scientific program committee 2001
 20 2 p. 108-
1 p.
 artikel
275 Short-term survival with combined heart-kidney or combined heart-liver transplantation with allografts from a single donor Murali, S.
 2001
 20 2 p. 168-
1 p.
 artikel
276 Single lung transplantation for pulmonary alveolar microlithiasis Jackson, K.B.
 2001
 20 2 p. 226-
1 p.
 artikel
277 Sirolimus(rapamycin) allows renal recovery in lung and heart transplant recipients with chronic renal impairment Snell, G.I.
 2001
 20 2 p. 163-164
2 p.
 artikel
278 Specialized, comprehensive care eliminates racial and gender differences in mortality between African American and Caucasian heart failure patients Pamboukian, S.V.
 2001
 20 2 p. 232-
1 p.
 artikel
279 Sponsors 2001
 20 2 p. 116-
1 p.
 artikel
280 Statins improve long-term survival and reduce incidence of hemodynamically significant rejection Stojanovic, I.
 2001
 20 2 p. 236-
1 p.
 artikel
281 Success of lung transplantation without surveillance bronchoscopy Valentine, V.G.
 2001
 20 2 p. 259-
1 p.
 artikel
282 Sudden death after heart transplantation: the major mode of death Shivkumar, K.
 2001
 20 2 p. 180-
1 p.
 artikel
283 Sudden, unexpected death in cardiac transplant recipients: an autopsy study. Blakey, J.D.
 2001
 20 2 p. 229-
1 p.
 artikel
284 Surgical management of severe emphysema in Australia: lung transplant and lung volume reduction surgery Munro, P.E.
 2001
 20 2 p. 218-
1 p.
 artikel
285 Surgical therapy for chronic thromboembolic pulmonary hypertension: criteria for choosing lung transplant vs trhomboendarterectomy D’Armini, A.M.
 2001
 20 2 p. 218-
1 p.
 artikel
286 Surgical treatment of post infarct left ventricular aneurysm tachyarrhythmias with cryoablation and endoaneurysmoraphy Wellens, F.
 2001
 20 2 p. 188-
1 p.
 artikel
287 Survival benefit of the implantable cardioverter/defibrillator in patients listed for cardiac transplantation Sandner, S.
 2001
 20 2 p. 252-
1 p.
 artikel
288 Survival of diabetic patients following cardiac transplant Mancini, D.
 2001
 20 2 p. 168-
1 p.
 artikel
289 Sustained production of the chemokine MIG precedes intimal thickening in chronic rejection Yun, J.J.
 2001
 20 2 p. 156-
1 p.
 artikel
290 Sustained rantes production is necessary for CAV development Yun, J.J.
 2001
 20 2 p. 185-
1 p.
 artikel
291 Swan Ganz catheter assessment of donor hearts - outcome of organs with borderline haemodynamics Stoica, S.C.
 2001
 20 2 p. 250-
1 p.
 artikel
292 Syncope following orthotopic heart transplantation Sangrigoli, R.M.
 2001
 20 2 p. 179-180
2 p.
 artikel
293 Systemic administration of recombinant human relaxin (RHRLX) ameliorates the acute cyclosporine nephrotoxicity in rats Huang, X.
 2001
 20 2 p. 253-
1 p.
 artikel
294 Systemic but not cardiac expression of P-selectin and ICAM-1 mediate coronary microcirculatory changes in cardiac transplant recipients Wildhirt, S.M.
 2001
 20 2 p. 197-
1 p.
 artikel
295 Systemic vasculitis complicating pig to primate xenotransplantation Goddard, M.J.
 2001
 20 2 p. 215-216
2 p.
 artikel
296 Systolic right ventricular dysfunction in ‘good’ donor hearts- a normal finding? Satchithananda, D.K.
 2001
 20 2 p. 243-
1 p.
 artikel
297 Tacrolimus/mycophenolate mofetil vs cyclosporine/mycophenolate mofetil: comparison of mycophenolate acid trough levels and coronary vasomotor function Groetzner, J.
 2001
 20 2 p. 191-
1 p.
 artikel
298 Tacrolimus versus cyclosporine after HTX: comparison of long-term effects Schirmer, J.
 2001
 20 2 p. 191-
1 p.
 artikel
299 TC99M MCP-1 imaging of chronic rejection in rat cardiac allografts Kown, M.H.
 2001
 20 2 p. 186-
1 p.
 artikel
300 Ten year experience of FK 506 for adult cardiac transplantation at a single institution Sakai, T.
 2001
 20 2 p. 191-192
2 p.
 artikel
301 The differential metabolic impact of tacrolimus and cyclosporine immunosuppression in black heart transplant recipients: hyperlipidemia, hypertension and hyperglycemia Uber, P.A.
 2001
 20 2 p. 192-
1 p.
 artikel
302 The dilemma of disability after heart transplantation Espejo, M.
 2001
 20 2 p. 244-
1 p.
 artikel
303 The diminishing impact of pretransplant pulmonary hypertension on perioperative mortality after cardiac transplantation Chen, J.M.
 2001
 20 2 p. 235-236
2 p.
 artikel
304 The effect of interleukin-6 gene polymorphisms on the outcome of cardiac transplantation Newell, H.
 2001
 20 2 p. 213-214
2 p.
 artikel
305 The effects of mycophenolate mofetil on cardiac allograft survival and cardiac allograft vasculopathy in miniature swine Schwarze, M.L.
 2001
 20 2 p. 160-
1 p.
 artikel
306 The emergence of co-morbid diseases impacting survival after cardiac transplantation, a ten year multi-institutional experience Bourge, R.C.
 2001
 20 2 p. 167-168
2 p.
 artikel
307 The growth enhancing effects of allograft inflammatory Factor-1 (AIF-1) in VSMC are dose-dependent and mediated by its ability to bind calcium Autieri, M.V.
 2001
 20 2 p. 198-
1 p.
 artikel
308 The impact of CD4 and CD8 transendothelial migration in the development of transplant arteriosclerosis following experimental cardiac transplantation Richter, M.H.
 2001
 20 2 p. 228-
1 p.
 artikel
309 The impact of changes in radiographic abnormalities in organ donors on successful lung donation McCowin, M.
 2001
 20 2 p. 242-243
2 p.
 artikel
310 The internal cardiac defibrillator for VT on LVAD support Roberts, S.R.
 2001
 20 2 p. 239-
1 p.
 artikel
311 The optimal pressure for initial flushout in heart procurement with the UW solution Mohara, J.
 2001
 20 2 p. 181-182
2 p.
 artikel
312 Therapeutic drug monitoring (TDM) of prednisolone in lung transplantation Morton, J.M.
 2001
 20 2 p. 192-
1 p.
 artikel
313 The role of indirect recognition of donor MHC class II peptides in cardiac transplantation in miniature swine Lee, R.S.
 2001
 20 2 p. 172-
1 p.
 artikel
314 The role of vitronectin receptor and tissue factor in the pathogenesis of transplant coronary vasculopathy Yamani, M.H.
 2001
 20 2 p. 185-
1 p.
 artikel
315 The TCR repertoire of proliferating T cells is restricted by immunodominant antigens in the direct human anti-pig pathway Popma, S.
 2001
 20 2 p. 215-
1 p.
 artikel
316 The use of ABO compatible non-identical organs for cardiac transplantation: are we treating potential recipients with blood group O fairly? Rexius, H.
 2001
 20 2 p. 207-
1 p.
 artikel
317 The value of exhaled co-measurement for detection of smoking after heart transplantation Riha, M.
 2001
 20 2 p. 236-
1 p.
 artikel
318 Time course and determinants of graft vascular remodelling in heart transplant recipients: a prospective study Potena, L.
 2001
 20 2 p. 195-
1 p.
 artikel
319 Timing of VAD bridging critical for outcome of adult heart transplantation Tenderich, G.
 2001
 20 2 p. 209-
1 p.
 artikel
320 Total depletion and suppression of natural and induced anti-pig antibodies in baboons Teranishi, K.
 2001
 20 2 p. 214-
1 p.
 artikel
321 Transbronchial lung biopsy for acute rejection is a safe procedure in lung transplant recipients Hopkins, P.
 2001
 20 2 p. 258-
1 p.
 artikel
322 Transplant coronary artery disease in pediatrics: favorable outcome with medical therapy Boucek, M.M.
 2001
 20 2 p. 261-
1 p.
 artikel
323 Treatment of respiratory syncytial viral and parainfluenza lower respiratory tract infection in lung transplant patients Hodges, T.N.
 2001
 20 2 p. 170-
1 p.
 artikel
324 Tumour necrosis factor- a A2 polymorphism; a predisposing factor to non-ischaemic myocardial dysfunction? Densem, C.
 2001
 20 2 p. 159-160
2 p.
 artikel
325 Twelve year experience with pediatric cardiac retransplantation Kanter, K.R.
 2001
 20 2 p. 231-
1 p.
 artikel
326 Upregulation of BCL-2 via hyperbaric pressure transfection of TGF- β1 ameliorates ischemia/reperfusion injury in rat cardiac allografts Grunenfelder, J.
 2001
 20 2 p. 154-
1 p.
 artikel
327 Upregulation of PAI-1 is mediated through TGF β /SMAD pathway in transplant arteriopathy Dong, C.
 2001
 20 2 p. 219-
1 p.
 artikel
328 Usefulness of post-transplant wall motion analysis by tissue Doppler imaging in patients with cardiac allograft vasculopathy: evaluation of functional severity and timing of follow-up cardiac catheterizations Dandel, M.
 2001
 20 2 p. 151-
1 p.
 artikel
329 Use of en face silver nitrate staining to assess endothelial gaps and vascular permeability in rat coronary artery transplant vasculopathy Dyck, J.
 2001
 20 2 p. 229-230
2 p.
 artikel
330 Use of hearts transplanted from donors with atraumatic intracranial bleeds Marelli, D.
 2001
 20 2 p. 256-
1 p.
 artikel
331 Use of long-term preserved organs in heart transplantation : post-operative results and long term follow up Sebbag, L.
 2001
 20 2 p. 182-183
2 p.
 artikel
332 Utility of sublingual tacrolimus in cystic fibrosis patients after lung transplantation Reams, D.
 2001
 20 2 p. 207-208
2 p.
 artikel
333 Vascular endothelial growth factor-D (VEGF-D) is an endothelial hyperpermeability inducing growth factor differentially expressed in human cardiac allografts Wong, D.
 2001
 20 2 p. 156-
1 p.
 artikel
334 Ventricular asynchrony after heart transplantation: prevalence and clinical correlates Potluri, S.
 2001
 20 2 p. 237-
1 p.
 artikel
335 Viral genome in the myocardium and outcomes in heart transplant recipients Bowles, N.
 2001
 20 2 p. 198-
1 p.
 artikel
336 Wall motion assessment by tissue Doppler imaging after heart transplantation: timing of endomyocardial biopsies and facilitation of therapeutic decisions during acute cardiac rejection Dandel, M.
 2001
 20 2 p. 213-
1 p.
 artikel
337 Who is most likely to enjoy long term survival after cardiac transplantation? Risk stratification in a 10 year multi-institutional experience Kirklin, J.
 2001
 20 2 p. 168-169
2 p.
 artikel
                             337 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland